Feed excerpt — reported by STAT News
With the sales growth of the cardiomyopathy medication Amvuttra slowing, the company's stock price has tumbled.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →